The brain imaging and neuroimaging market is anticipated to flourish at an average CAGR of 5.1% between 2023 and 2033. The market is expected to hold a market share of US$ 22.41 billion by 2033, while the market is likely to reach a value of US$ 13.69 billion in 2023.
| Attributes | Details |
|---|---|
| Brain Imaging and Neuroimaging Market CAGR (2023 to 2033) | 5.1% |
| Brain Imaging and Neuroimaging Market Size (2023) | US$ 13.69 billion |
| Brain Imaging and Neuroimaging Market Size (2033) | US$ 22.41 billion |
The brain imaging and neuroimaging market are primarily driven by factors such as the rising incidence and prevalence of neurological disorders, increased awareness of neurodegenerative diseases, an increase in traumatic brain injuries, and increased applications of brain imaging and neuroimaging in clinical trials.
Rising demand for non-invasive and minimally invasive devices, expanding therapeutic applications of brain imaging and neuroimaging devices, and the expanding healthcare market in emerging economies are all expected to provide growth opportunities for market participants.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The global demand for brain imaging and neuroimaging is projected to increase at a CAGR of 5.1% during the forecast period between 2023 and 2033, reaching a total of US$ 22.41 billion in 2033, according to a report from Future Market Insights (FMI). From 2018 to 2022, sales witnessed significant growth, registering a CAGR of 3.2%.
The growing prevalence of neurological disorders, the growing geriatric population, and emerging product trends are some factors driving the market growth. The rising prevalence of neurological disorders, combined with an aging population more prone to developing neurodegenerative diseases such as Parkinson's, Alzheimer's, dementia, epilepsy, and others, are expected to drive growth in the brain imaging and neuroimaging market.
The growing global geriatric population is expected to play a significant role in the growth of the studied market because they are more vulnerable to various neurological disorders and injuries as they age, and when combined with new technological advancements, the studied market is forecasted to grow during the projected period. However, a scarcity of skilled professionals is expected to limit the growth of the brain imaging and neuroimaging market over the projected period.
Rising Global Incidence of Brain Cancer to Promote Market Growth
The rising global incidence of brain cancer, combined with rising rates of neurodegenerative disorders, is expected to fuel the growth of the global brain imaging market. The introduction of innovative products by key imaging segment players is also expected to drive the overall brain imaging and neuroimaging market.
Increasing road accidents around the world are anticipated to drive the market during the forecast period. One of the drivers expected to increase the revenue of the brain imaging market is technological advancements in imaging techniques and the availability of reimbursement programs for various types of imaging tests, including brain imaging.
Principal Consultant
High Cost of Imaging Techniques to Impede Market Growth
The high cost of imaging techniques is a key impediment to global brain imaging and neuroimaging market growth. Furthermore, one of the market restraints for brain imaging is a shortage of awareness and the absence of scanners in remote areas.
| Countries | Revenue Share % (2022) |
|---|---|
| United States | 33.8% |
| Germany | 8.8% |
| Japan | 3.5% |
| North America | 37.8% |
| Europe | 32.2% |
| Countries | CAGR % (2023 to 2033) |
|---|---|
| China | 6.3% |
| India | 5.% |
| United Kingdom | 3.6% |
| Australia | 4.6% |
Rise in Disease Prevalence Creating Opportunities for Brain Imaging and Neuroimaging Manufacturers.
Over the forecast period, North America is expected to have the largest market share. The rise in funding for various neurodegenerative disease research, the rise in disease prevalence and awareness, and the presence of key market players are the crucial factors contributing to the growth of the studied market. According to the Parkinson's Foundation, around one billion people in the United States had Parkinson's disease (PD) in 2020, and nearly 60,000 Americans are diagnosed with Parkinson's disease each year.
According to the National Institute of Health, funding for neurodegenerative diseases was US$ 4,021 million in 2020, and it is expected to increase to US$ 4,110 million in 2021. Rising research funding is expected to attract the majority of the key players, resulting in the market's rapid growth under consideration. Thus, for the aforementioned reasons, North America possessed a 37.8% market share in 2022, registering a CAGR of 4.9% for the market from 2023 to 2033.
Increasing Prevalence of Brain Cancer Favoring the Market Growth
The increasing prevalence of brain cancer and neurodegenerative disorders is expected to dominate the overall brain imaging market in Western Europe, over the forecast period. Thus, Europe held 32.2% of the market share for the brain imaging and neuroimaging market in 2022.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
| Category | By Imaging Type |
|---|---|
| Leading Segment | Computed Tomography |
| Market Share (2022) | 28.7% |
| Category | By End User |
|---|---|
| Leading Segment | Hospitals |
| Market Share (2022) | 43.20% |
Hospitals to Hold Lion’s Share in the Brain Imaging and Neuroimaging Market
End users in the global brain imaging and neuroimaging market include hospitals, ambulatory surgical centers, clinics, and diagnostic centers. In 2020, the hospital segment held a leading brain imaging and neuroimaging market share. Brain imaging and neuroimaging is a complex process that necessitates the use of expensive and sophisticated devices and equipment typically found in hospitals.
In addition, hospitals receive significantly more patients than small clinics and other end users. Furthermore, brain imaging and neuroimaging impose a significant burden on healthcare facilities in terms of maintenance costs; hospitals, more than other end users, can bear such costs. As a result, brain imaging and neuroimaging are mostly used in hospitals, which account for the lion's share of this market segment.
Brain Imaging to Have a Massive Demand in the Market
In recent years, the healthcare industry has seen technological advances in medical devices that provide robust services to patients suffering from brain-related diseases. Brain imaging is currently one of the fast-growing segments of the imaging market.
Brain imaging is a screening method that allows doctors to analyze the activity and functioning of the nervous system in order to treat various types of neurodegenerative disorders. Various types of scanners are available on the market to provide services in the brain imaging segment. Brain imaging devices include functional magnetic resonance imaging (fMRI), computed tomography (CT), positron emission tomography (PET), electroencephalography (EEG), magnetoencephalography (MEG), and near-infrared spectroscopy (NIRS).
Among these, functional magnetic resonance imaging (fMRI) is well-known for providing detailed information about brain activity by detecting changes in blood oxygenation. Anatomical and functional information about changes in blood flow to specific areas of the brain is also provided by functional magnetic resonance imaging (fMRI). Brain imaging is widely used in the diagnosis of neurodegenerative diseases like Alzheimer's and Parkinsonism, as well as chronic diseases like brain cancer.
Key Start-up Players in the Brain Imaging and Neuroimaging Market are:
Key brain imaging and neuroimaging players include Varian Medical Systems, General Electric Company, Siemens AG, Philips Healthcare, Toshiba Medical Systems, Hitachi Medical Systems, Esaote SpA, and Sanrad Medical Systems Pvt. Ltd.
The strip pack market is bolstered by consumer desire for compact and portable packaging.
Through 2033, the market is projected to develop at a CAGR of 5.1%.
By 2033, the industry is to have expanded to US$ 22.41 billion.
In 2023, the market to reach a worth of US$ 13.69 billion.
Between 2018 and 2022, sales surged at a CAGR of 3.2%.
The United States is expected to account for around 33.8% of the global market share.
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Investment Feasibility Matrix
3.5. PESTLE and Porter’s Analysis
3.6. Regulatory Landscape
3.6.1. By Key Regions
3.6.2. By Key Countries
3.7. Regional Parent Market Outlook
4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033
4.1. Historical Market Size Value (US$ Million) Analysis, 2018 to 2022
4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Imaging Type
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Million) Analysis By Imaging Type, 2018 to 2022
5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Imaging Type, 2023 to 2033
5.3.1. Functional Magnetic Resonance Imaging (fMRI)
5.3.2. Computed Tomography (CT)
5.3.3. Positron Emission Tomography (PET)
5.3.4. Electroencephalography (EEG)
5.3.5. Magnetoencephalography (MEG)
5.3.6. Near Infrared Spectroscopy (NIRS)
5.4. Y-o-Y Growth Trend Analysis By Imaging Type, 2018 to 2022
5.5. Absolute $ Opportunity Analysis By Imaging Type, 2023 to 2033
6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End User
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Million) Analysis By End User, 2018 to 2022
6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End User, 2023 to 2033
6.3.1. Hospitals
6.3.2. Ambulatory Surgical Centers
6.3.3. Clinics and Diagnostic Centers
6.4. Y-o-Y Growth Trend Analysis By End User, 2018 to 2022
6.5. Absolute $ Opportunity Analysis By End User, 2023 to 2033
7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region
7.1. Introduction
7.2. Historical Market Size Value (US$ Million) Analysis By Region, 2018 to 2022
7.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033
7.3.1. North America
7.3.2. Latin America
7.3.3. Western Europe
7.3.4. Eastern Europe
7.3.5. South Asia and Pacific
7.3.6. East Asia
7.3.7. Middle East and Africa
7.4. Market Attractiveness Analysis By Region
8. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
8.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
8.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
8.2.1. By Country
8.2.1.1. USA
8.2.1.2. Canada
8.2.2. By Imaging Type
8.2.3. By End User
8.3. Market Attractiveness Analysis
8.3.1. By Country
8.3.2. By Imaging Type
8.3.3. By End User
8.4. Key Takeaways
9. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
9.2.1. By Country
9.2.1.1. Brazil
9.2.1.2. Mexico
9.2.1.3. Rest of Latin America
9.2.2. By Imaging Type
9.2.3. By End User
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Imaging Type
9.3.3. By End User
9.4. Key Takeaways
10. Western Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
10.2.1. By Country
10.2.1.1. Germany
10.2.1.2. UK
10.2.1.3. France
10.2.1.4. Spain
10.2.1.5. Italy
10.2.1.6. Rest of Western Europe
10.2.2. By Imaging Type
10.2.3. By End User
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Imaging Type
10.3.3. By End User
10.4. Key Takeaways
11. Eastern Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
11.2.1. By Country
11.2.1.1. Poland
11.2.1.2. Russia
11.2.1.3. Czech Republic
11.2.1.4. Romania
11.2.1.5. Rest of Eastern Europe
11.2.2. By Imaging Type
11.2.3. By End User
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Imaging Type
11.3.3. By End User
11.4. Key Takeaways
12. South Asia and Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
12.2.1. By Country
12.2.1.1. India
12.2.1.2. Bangladesh
12.2.1.3. Australia
12.2.1.4. New Zealand
12.2.1.5. Rest of South Asia and Pacific
12.2.2. By Imaging Type
12.2.3. By End User
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Imaging Type
12.3.3. By End User
12.4. Key Takeaways
13. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
13.2.1. By Country
13.2.1.1. China
13.2.1.2. Japan
13.2.1.3. South Korea
13.2.2. By Imaging Type
13.2.3. By End User
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Imaging Type
13.3.3. By End User
13.4. Key Takeaways
14. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
14.2.1. By Country
14.2.1.1. GCC Countries
14.2.1.2. South Africa
14.2.1.3. Israel
14.2.1.4. Rest of MEA
14.2.2. By Imaging Type
14.2.3. By End User
14.3. Market Attractiveness Analysis
14.3.1. By Country
14.3.2. By Imaging Type
14.3.3. By End User
14.4. Key Takeaways
15. Key Countries Market Analysis
15.1. USA
15.1.1. Pricing Analysis
15.1.2. Market Share Analysis, 2022
15.1.2.1. By Imaging Type
15.1.2.2. By End User
15.2. Canada
15.2.1. Pricing Analysis
15.2.2. Market Share Analysis, 2022
15.2.2.1. By Imaging Type
15.2.2.2. By End User
15.3. Brazil
15.3.1. Pricing Analysis
15.3.2. Market Share Analysis, 2022
15.3.2.1. By Imaging Type
15.3.2.2. By End User
15.4. Mexico
15.4.1. Pricing Analysis
15.4.2. Market Share Analysis, 2022
15.4.2.1. By Imaging Type
15.4.2.2. By End User
15.5. Germany
15.5.1. Pricing Analysis
15.5.2. Market Share Analysis, 2022
15.5.2.1. By Imaging Type
15.5.2.2. By End User
15.6. UK
15.6.1. Pricing Analysis
15.6.2. Market Share Analysis, 2022
15.6.2.1. By Imaging Type
15.6.2.2. By End User
15.7. France
15.7.1. Pricing Analysis
15.7.2. Market Share Analysis, 2022
15.7.2.1. By Imaging Type
15.7.2.2. By End User
15.8. Spain
15.8.1. Pricing Analysis
15.8.2. Market Share Analysis, 2022
15.8.2.1. By Imaging Type
15.8.2.2. By End User
15.9. Italy
15.9.1. Pricing Analysis
15.9.2. Market Share Analysis, 2022
15.9.2.1. By Imaging Type
15.9.2.2. By End User
15.10. Poland
15.10.1. Pricing Analysis
15.10.2. Market Share Analysis, 2022
15.10.2.1. By Imaging Type
15.10.2.2. By End User
15.11. Russia
15.11.1. Pricing Analysis
15.11.2. Market Share Analysis, 2022
15.11.2.1. By Imaging Type
15.11.2.2. By End User
15.12. Czech Republic
15.12.1. Pricing Analysis
15.12.2. Market Share Analysis, 2022
15.12.2.1. By Imaging Type
15.12.2.2. By End User
15.13. Romania
15.13.1. Pricing Analysis
15.13.2. Market Share Analysis, 2022
15.13.2.1. By Imaging Type
15.13.2.2. By End User
15.14. India
15.14.1. Pricing Analysis
15.14.2. Market Share Analysis, 2022
15.14.2.1. By Imaging Type
15.14.2.2. By End User
15.15. Bangladesh
15.15.1. Pricing Analysis
15.15.2. Market Share Analysis, 2022
15.15.2.1. By Imaging Type
15.15.2.2. By End User
15.16. Australia
15.16.1. Pricing Analysis
15.16.2. Market Share Analysis, 2022
15.16.2.1. By Imaging Type
15.16.2.2. By End User
15.17. New Zealand
15.17.1. Pricing Analysis
15.17.2. Market Share Analysis, 2022
15.17.2.1. By Imaging Type
15.17.2.2. By End User
15.18. China
15.18.1. Pricing Analysis
15.18.2. Market Share Analysis, 2022
15.18.2.1. By Imaging Type
15.18.2.2. By End User
15.19. Japan
15.19.1. Pricing Analysis
15.19.2. Market Share Analysis, 2022
15.19.2.1. By Imaging Type
15.19.2.2. By End User
15.20. South Korea
15.20.1. Pricing Analysis
15.20.2. Market Share Analysis, 2022
15.20.2.1. By Imaging Type
15.20.2.2. By End User
15.21. GCC Countries
15.21.1. Pricing Analysis
15.21.2. Market Share Analysis, 2022
15.21.2.1. By Imaging Type
15.21.2.2. By End User
15.22. South Africa
15.22.1. Pricing Analysis
15.22.2. Market Share Analysis, 2022
15.22.2.1. By Imaging Type
15.22.2.2. By End User
15.23. Israel
15.23.1. Pricing Analysis
15.23.2. Market Share Analysis, 2022
15.23.2.1. By Imaging Type
15.23.2.2. By End User
16. Market Structure Analysis
16.1. Competition Dashboard
16.2. Competition Benchmarking
16.3. Market Share Analysis of Top Players
16.3.1. By Regional
16.3.2. By Imaging Type
16.3.3. By End User
17. Competition Analysis
17.1. Competition Deep Dive
17.1.1. Varian Medical Systems
17.1.1.1. Overview
17.1.1.2. Product Portfolio
17.1.1.3. Profitability by Market Segments
17.1.1.4. Sales Footprint
17.1.1.5. Strategy Overview
17.1.1.5.1. Marketing Strategy
17.1.2. General Electric Company
17.1.2.1. Overview
17.1.2.2. Product Portfolio
17.1.2.3. Profitability by Market Segments
17.1.2.4. Sales Footprint
17.1.2.5. Strategy Overview
17.1.2.5.1. Marketing Strategy
17.1.3. Siemens AG
17.1.3.1. Overview
17.1.3.2. Product Portfolio
17.1.3.3. Profitability by Market Segments
17.1.3.4. Sales Footprint
17.1.3.5. Strategy Overview
17.1.3.5.1. Marketing Strategy
17.1.4. Philips Healthcare
17.1.4.1. Overview
17.1.4.2. Product Portfolio
17.1.4.3. Profitability by Market Segments
17.1.4.4. Sales Footprint
17.1.4.5. Strategy Overview
17.1.4.5.1. Marketing Strategy
17.1.5. Toshiba Medical Systems
17.1.5.1. Overview
17.1.5.2. Product Portfolio
17.1.5.3. Profitability by Market Segments
17.1.5.4. Sales Footprint
17.1.5.5. Strategy Overview
17.1.5.5.1. Marketing Strategy
17.1.6. Hitachi Medical Systems
17.1.6.1. Overview
17.1.6.2. Product Portfolio
17.1.6.3. Profitability by Market Segments
17.1.6.4. Sales Footprint
17.1.6.5. Strategy Overview
17.1.6.5.1. Marketing Strategy
17.1.7. Esaote SpA
17.1.7.1. Overview
17.1.7.2. Product Portfolio
17.1.7.3. Profitability by Market Segments
17.1.7.4. Sales Footprint
17.1.7.5. Strategy Overview
17.1.7.5.1. Marketing Strategy
17.1.8. Sanrad Medical Systems Pvt. Ltd
17.1.8.1. Overview
17.1.8.2. Product Portfolio
17.1.8.3. Profitability by Market Segments
17.1.8.4. Sales Footprint
17.1.8.5. Strategy Overview
17.1.8.5.1. Marketing Strategy
17.1.9. NeuroSoft
17.1.9.1. Overview
17.1.9.2. Product Portfolio
17.1.9.3. Profitability by Market Segments
17.1.9.4. Sales Footprint
17.1.9.5. Strategy Overview
17.1.9.5.1. Marketing Strategy
17.1.10. Medtronic Plc
17.1.10.1. Overview
17.1.10.2. Product Portfolio
17.1.10.3. Profitability by Market Segments
17.1.10.4. Sales Footprint
17.1.10.5. Strategy Overview
17.1.10.5.1. Marketing Strategy
18. Assumptions & Acronyms Used
19. Research Methodology
Explore Healthcare Insights
View Reports
Brain Imaging And Neuroimaging Market
